| PACKAGING TYPE: | 10x10 Alu-alu In C-box |
| COMPOSITION: | Atorvastatin 10 Mg , Ezetimibe 10 Mg |
| FORMULATION: | Tablets |
| Description: | AROVAST EZ 10/10 Tablet is a combination lipid-lowering medication containing Atorvastatin 10 mg and Ezetimibe 10 mg. It is indicated for the management of primary hypercholesterolemia and mixed dyslipidemia in patients who require greater LDL cholesterol reduction than can be achieved with statin therapy alone. The dual-action formulation improves lipid profiles and supports long-term cardiovascular health when combined with a healthy diet, regular exercise, and lifestyle modifications under medical supervision. |
| Side Effects: | Muscle pain or weakness Headache Nausea Abdominal discomfort Elevated liver enzymes Fatigue |
| How to Use: | Take as prescribed by the physician Swallow the tablet whole with water Can be taken with or without food Take at the same time every day Continue following a cholesterol-lowering diet during treatment |
| Precaution: | Use only under medical supervision Regular monitoring of liver function and lipid profile may be required Inform your doctor if you have liver disease, kidney disease, or a history of muscle disorders Avoid excessive alcohol consumption Do not use during pregnancy or breastfeeding unless specifically advised by your physician Store in a cool, dry place away from direct sunlight |
| Product Benefits: | Effectively lowers LDL (bad) cholesterol Helps reduce total cholesterol and triglyceride levels Increases HDL (good) cholesterol Dual-action formula for enhanced lipid control Supports cardiovascular health Helps reduce the risk of heart attack and s |
| Expiry Date: | 2028-06-30 |
Frequently Asked Questions
AROVAST EZ 10/10 Tablet is used for the treatment of high cholesterol (hypercholesterolemia) and mixed dyslipidemia. It helps lower LDL (bad) cholesterol and reduces the risk of cardiovascular events such as heart attack and stroke.
It contains Atorvastatin 10 mg and Ezetimibe 10 mg.
Atorvastatin reduces cholesterol production in the liver by inhibiting the HMG-CoA reductase enzyme, while Ezetimibe blocks cholesterol absorption from the small intestine. Together, they provide complementary cholesterol-lowering effects.










